Increasing trend in gonococcal resistance to ciprofloxacin in The Netherlands, 2006-8

Koedijk, Femke D. H.; Veen, Maaike G. van; Neeling, Albert J. de; Linde, G.B.; Sande, Marianne A. B. van der

doi:10.1136/sti.2009.037135

Cited by 21 publications

(32 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Genital warts were the most frequently diagnosed viral STI reported in all Dutch STI centres in 2008 29. In women with genital warts, 59% was younger than 25 years, and for 11% a history of gonorrhoea, infectious syphilis or Chlamydia infection was reported 29. Similar to our study, earlier studies have shown an independent association between diagnosed ever with an STI and HPV infection 16 30.…”

Section: Discussionsupporting

confidence: 85%

“…In the present study, HPV6 and/or -11 infections were found from the age of 13 years onwards and increased with age. Genital warts were the most frequently diagnosed viral STI reported in all Dutch STI centres in 2008 29. In women with genital warts, 59% was younger than 25 years, and for 11% a history of gonorrhoea, infectious syphilis or Chlamydia infection was reported 29.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Age-specific HPV seroprevalence among young females in The Netherlands

Kramer

Mollema²,

Smits³

et al. 2010

Sexually Transmitted Infections

View full text Add to dashboard Cite

Objectives: To obtain insight into the age-specific seroprevalence for human papillomavirus (HPV) 6, 11, 16, and 18 among females before introduction of HPV vaccination in the Netherlands. Methods:In a population-based study in The Netherlands, 637 sera of 11-26-year-old females were tested for HPV6/11/16/18 antibodies. Sera were tested using a competitive Luminex assay with neutralizing monoclonal antibodies specific for each serotype.Associations between HPV seropositivity, demographics, and sexual behaviour were studied with logistic regression. Seroprevalences were standardized for age and urbanization degree to the general female population in the Netherlands. Results:Overall prevalence of antibodies against HPV6/11/16/18 was 7.9%. 4.3% had antibodies against HPV types 6/11, and 4.4% had antibodies against HPV types 16/18. HPV seropositivity significantly increased with age (OR 1.2; 95%CI 1.1-1.4), starting at the age of 16 years (median age of sexual debut in The Netherlands). A former diagnosis with sexually transmitted infections was also significantly associated with HPV seropositivity (OR 6.3; 95%CI 2.2-17.9). Conclusions:In addition to 12-year-old girls who are targeted for routine HPV vaccination, also girls up to 16 years are likely to benefit substantially from HPV16/18 vaccination.

show abstract

Section: Discussionsupporting

confidence: 85%

Section: Discussionmentioning

confidence: 99%

Age-specific HPV seroprevalence among young females in The Netherlands

Kramer

Mollema²,

Smits³

et al. 2010

Sexually Transmitted Infections

View full text Add to dashboard Cite

show abstract

“…15 For ciprofloxacin, men and those older than 30 years were associated with resistance in Ontario, with heterosexuals appearing to significantly contribute to the ciprofloxacin resistance. 16 In The Netherlands, MSM and women older than 35 years 17 were associated with ciprofloxacin resistance, whereas MSM association with ciprofloxacin resistance was clinic dependent in California. 18 It is difficult to compare these studies that used multivariable analyses to identify risk factors as the study populations, variables, time, and location vary greatly.…”

Section: Discussionmentioning

confidence: 97%

Risk Factors for Antimicrobial-Resistant Neisseria gonorrhoeae in Europe

Cole¹,

Spiteri²,

Town³

et al. 2014

Sexually Transmitted Diseases

View full text Add to dashboard Cite

The linking of epidemiological and behavioral data to the susceptibility profiles of the gonococcal isolates has allowed those at higher risk for acquiring antimicrobial resistant Neisseria gonorrhoeae to be identified. Improved data numbers and representativeness are required before evidence-based risk groups can be identified, and subsequent focused treatments or public health intervention strategies can be initiated with confidence.

show abstract

“…The choice is often made for practical reasons depending on resources available and numbers of cases (and hence isolates to be tested). Surveillance programmes for monitoring antimicrobial resistance in gonorrhoea include both those with comprehensive and continuous sampling (eg, Scotland,5 the Netherlands,6 Australia7) and those which are sentinel (eg, USA8). It is important that sample-based programmes are designed to permit reliable estimation of resistance prevalence in the population as a whole as well as in the main population subgroups at particular risk.…”

Section: Introductionmentioning

confidence: 99%

Estimating the prevalence of gonococcal resistance to antimicrobials in England and Wales

Hughes¹,

Nichols²,

Ison³

2011

Sex Transm Infect

View full text Add to dashboard Cite

Although over-representing MSM and under-representing women and heterosexual men, GRASP has provided reliable estimates of resistance prevalence in England and Wales. However, weighting for the national distribution of patient characteristics should be considered in future. As resistance usually emerges in MSM, enhanced surveillance of high-risk populations could enable development of more tailored (and therefore optimal) treatment strategies.

show abstract

Increasing trend in gonococcal resistance to ciprofloxacin in The Netherlands, 2006-8

Cited by 21 publications

References 19 publications

Age-specific HPV seroprevalence among young females in The Netherlands

Age-specific HPV seroprevalence among young females in The Netherlands

Risk Factors for Antimicrobial-Resistant Neisseria gonorrhoeae in Europe

Estimating the prevalence of gonococcal resistance to antimicrobials in England and Wales

Contact Info

Product

Resources

About